Fluvoxamine Dosing for OCD
For adults with OCD, start fluvoxamine at 50 mg once daily at bedtime, then increase by 50 mg every 4-7 days as tolerated to a target range of 100-300 mg/day, with doses above 100 mg split into two divided doses (larger dose at bedtime). 1
Adult Dosing Algorithm
Initial Phase:
- Start: 50 mg once daily at bedtime 1
- Titration: Increase by 50 mg increments every 4-7 days based on tolerability 1
- Target range: 100-300 mg/day (established in controlled trials) 1
Dosing Schedule:
- ≤100 mg/day: Single daily dose at bedtime 1
100 mg/day: Split into two divided doses, with the larger dose at bedtime 1
- Maximum: 300 mg/day 1
Treatment Duration:
- Allow 8-12 weeks at therapeutic dose to assess efficacy 2
- Note: Significant improvement may be observed within 2 weeks, with greatest gains occurring early in treatment 2, 3
Pediatric Dosing (Ages 8-17)
For children and adolescents, start at 25 mg once daily at bedtime, increase by 25 mg every 4-7 days, with maximum doses of 200 mg/day for children ≤11 years (especially females who require lower doses) and up to 300 mg/day for adolescents. 1
Age-Specific Considerations:
Children (8-11 years):
Adolescents (12-17 years):
Dosing Schedule for Pediatrics:
- ≤50 mg/day: Single daily dose at bedtime 1
50 mg/day: Split into two divided doses, larger dose at bedtime 1
Special Populations
Elderly or Hepatically Impaired:
- Use slower titration due to 50% reduced clearance and 40% higher peak concentrations 1
- Start at lower doses and increase more gradually 1
Key Clinical Considerations
Efficacy Expectations:
- Response rate (≥25% symptom reduction): 38-52% with fluvoxamine vs 0-18% with placebo 5
- Mean Y-BOCS reduction: 4-5 units vs 2 units with placebo 1
- Early response at week 2 predicts sustained benefit 3
Common Pitfalls:
- Underdosing: OCD requires higher SSRI doses than depression or other anxiety disorders 2
- Inadequate trial duration: Must allow full 8-12 weeks at therapeutic dose before declaring treatment failure 2
- Ignoring gender differences in children: Female children have significantly higher drug exposure and may need lower doses 1, 4
- Single daily dosing at high doses: Doses >100 mg (adults) or >50 mg (pediatrics) should be split to improve tolerability 1
Tolerability:
- Most common adverse events: nausea (>10%), somnolence, asthenia, headache 5
- Higher doses associated with greater efficacy but also higher dropout rates 2
- Generally better tolerated than clomipramine with similar efficacy 2, 5
Maintenance: